Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients
Authors:
- Vincent O MalletVMVincent O Mallet
- Aditi VarthamanAVAditi Varthaman
- Dominique LasneDLDominique Lasne
- Jean-Paul ViardJVJean-Paul Viard
- Hervé GouyaHGHervé Gouya
- Delphine BorgelDBDelphine Borgel
- Sébastien Lacroix-DesmazesSLSébastien Lacroix-Desmazes
- Stanislas PolSPStanislas Pol
- 31 July 2009
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 23 (12) , 1511-1518
Abstract
To identify the mechanism of nodular regenerative hyperplasia in HIV-infected patients. Case-control study. The hepatology and the infectious disease units of two tertiary care centers in France. We compared 13 consecutive HIV-positive patients with unexplained nodular regenerative hyperplasia to 16 consecutive HIV-positive patients without nodular regenerative hyperplasia, to eight HIV-negative patients with nodular regenerative hyperplasia from an identified cause and to 10 anonymous healthy blood donors. Patients and controls were screened for diminished protein S activity and antiprotein S immunoglobulin G (IgG) antibodies. The antiprotein S activity of purified IgG from patients and controls was assessed in a functional test of activation of protein C in which protein S serves as a cofactor. A full liver CT portography was realized on the liver explant of a case patient. The CT portography disclosed diffuse obliterative portal venopathy. Levels of protein S activity were lower among patients with HIV-associated nodular regenerative hyperplasia when compared with HIV-positive patients without nodular regenerative hyperplasia and when compared with HIV-negative patients with nodular regenerative hyperplasia (P < 0.005 for all comparisons). HIV-positive patients with nodular regenerative hyperplasia had significantly higher levels of antiprotein S IgG than HIV-positive patients without nodular regenerative hyperplasia and healthy controls. Purified IgG from patients with HIV-associated nodular regenerative hyperplasia specifically inhibited the protein S-dependent protein C activation. Acquired autoimmune protein S paucity and secondary thrombophilia appear to be causes of obliterative portal venopathy and compensatory nodular regenerative hyperplasia in HIV-positive patients.Keywords
This publication has 26 references indexed in Scilit:
- Response to Mallet et al., ‘Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients’AIDS, 2007
- Nodular regenerative hyperplasia of liver as a consequence of ARTAIDS, 2007
- Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patientsAIDS, 2007
- Liver‐related mortality in human‐immunodeficiency‐virus‐infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)*Journal of Viral Hepatitis, 2006
- Nodular regenerative hyperplasia of the liver after IL-2 therapy in an HIV-infected patientAIDS, 2006
- The effect of combination antiretroviral therapy on CD5 B‐ cells, B‐cell activation and hypergammaglobulinaemia in HIV‐1‐infected patientsHIV Medicine, 2005
- Unusual Thromboses Associated with Protein S Deficiency in Patients with Acquired Immunodeficiency Syndrome: Case Reports and Review of the LiteratureAIDS Research and Human Retroviruses, 2005
- Sarcoidosis in HIV‐Infected Patients in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2004
- Protein S Deficiency and HIV InfectionNew England Journal of Medicine, 1991
- Nodular Regenerative Hyperplasia of the Liver in Hematologic DisordersMedicine, 1980